Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition

Molecular and Cellular Biology

Volumn 27, Issue 13, 2007, Pages 4626-4640

  Susaki, Etsuo ^a,b   Nakayama, Keiko ^b,c   Nakayama, Keiichi I ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; RNA INTERFERENCE; UPREGULATION;

ANIMALS; CELL LINE; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DOWN-REGULATION; G0 PHASE; G1 PHASE; GENE EXPRESSION; HUMANS; MICE; MODELS, BIOLOGICAL; NIH 3T3 CELLS; PHOSPHORYLATION; PHOSPHOTHREONINE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; UP-REGULATION;

EID: 34347360771     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00862-06     Document Type: Article

References (83)

1. kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol. Cell. Biol. 16:4327-4336.
2. Alt, J. R., J. L. Cleveland, M. Hannink, and J. A. Diehl. 2000. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14:3102-3114.
3. Cip1 promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J. Biol. Chem. 277:8517-8523.
4. Baker, G. L., M. W. Landis, and P. W. Hinds. 2005. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation. Cell Cycle 4:330-338.
5. Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-821.
6. Kip1 and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Oncogene 20:7352-7367.
7. Bates, S., L. Bonetta, D. MacAllan, D. Parry, A. Holder, C. Dickson, and G. Peters. 1994. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene 9:71-79.
8. Kip1 stability, subcellular localization, and tumor suppression. Genes Dev. 20:47-64.
9. Kip1 and regulates cell cycle progression. EMBO J. 21:3390-3401.
10. Burns, K. H., J. E. Agno, P. Sicinski, and M. M. Matzuk. 2003. Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice. Mol. Endocrinol. 17:2053-2069.
11. Busk, P. K., R. Hinrichsen, J. Bartkova, A. H. Hansen, T. E. Christoftersen, J. Bartek, and S. Haunso. 2005. Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy. Exp. Cell Res. 304:149-161.
12. Carrano, A. C., E. Eytan, A. Hershko, and M. Pagano. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193-199.
13. Carthon, B. C., C. A. Neumann, M. Das, B. Pawlyk, T. Li, Y. Geng, and P. Sicinski. 2005. Genetic replacement of cyclin D1 function in mouse development by cyclin D2. Mol. Cell. Biol. 25:1081-1088.
14. Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA 95:1091-1096.
15. Chu, I., J. Sun, A. Arnaout, H. Kahn, W. Hanna, S. Narod, P. Sun, C. K. Tan, L. Hengst, and J. Slingerland. 2007. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 128:281-294.
16. Kip1 involves a nuclear export signal and links p27 export and proteolysis. Mol. Biol. Cell 14:201-213.
17. 0 by Mirk/dyrk1B kinase. J. Biol. Chem. 279:22498-22504.
18. Diehl, J. A., M. Cheng, M. F. Roussel, and C. J. Sherr. 1998. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499-3511.
19. Diehl, J. A., F. Zindy, and C. J. Sherr. 1997. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:957-972.
20. Dulic, V., L. F. Drullinger, E. Lees, S. I. Reed, and G. H. Stein. 1993. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc. Natl. Acad. Sci. USA 90:11034-11038.
21. Ewen, M. E, H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
22. Kip1 is haplo-insufficient for tumour suppression. Nature 396:177-180.
23. Kip1-deficient mice. Cell 85:733-744.
24. Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J. Biol. Chem. 277:28706-28713.
25. Ganter, B., S. Fu, and J. S. Lipsick. 1998. D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain. EMBO J. 17:255-268.
26. Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128:269-280.
27. 1 phase of the cell cycle. Mol. Cell. Biol. 25:9292-9303.
28. 1 transition mediated by a Skp2-independent ubiquitination pathway. J. Biol. Chem. 276:48937-48943.
29. Kip1 accumulation during the cell cycle. Science 271:1861-1864.
30. Huang, W., H. Y. Chang, T. Fei, H. Wu, and Y. G. Chen. 2007. GSK3β mediates suppression of cyclin D2 expression by tumor suppressor PTEN. Oncogene 26:2471-2482.
31. Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277:14355-14358.
32. Kip1, increases its protein stability. J. Biol. Chem. 275:25146-25154.
33. Kip1 at G1 phase. Nat. Cell Biol. 6:1229-1235.
34. Kato, J. Y., and C., J. Sherr. 1993. Inhibition of granulocyte differentiation by Gl cyclins D2 and D3 but not D1. Proc. Natl. Acad. Sci. USA 90:11513-11517.
35. Kerkhoff, E., and E. B. Ziff. 1995. Cyclin D2 and Ha-Ras transformed rat embryo fibroblasts exhibit a novel deregulation of cell size control and early S phase arrest in low serum. EMBO J. 14:1892-1903.
36. Kitagawa, M., H. Higashi, H. K. Jung, I. Suzuki-Takahashi, M. Ikeda, K. Tamai, J. Kato, K. Segawa, E. Yoshida, S. Nishimura, and Y. Taya. 1996. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15:7060-7069.
37. Kip1. Cell 85:721-732.
38. Kip1 in cyclin D2 transgenic mouse mammary gland during development. Oncogene 21:7214-7225.
39. Kotake, Y., K. Nakayama, N. Ishida, and K. I. Nakayama. 2005. Role of serine 10 phosphorylation in p27 stabilization revealed by analysis of p27 knock-in mice harboring a serine 10 mutation. J. Biol. Chem. 280:1095-1102.
40. Kotoshiba, S., T. Kamura, T. Hara, N. Ishida, and K. I. Nakayama. 2005. Molecular dissection of the interaction between p27 and Kip1 ubiquitylation-promoting complex, the ubiquitin ligase that regulates proteolysis of p27 in G1 phase. J. Biol. Chem. 280:17694-17700.
41. Kozar, K., M. A. Ciemerych, V. I. Rebel, H. Shigematsu, A. Zagozdzon, E. Sicinska, Y. Geng, Q. Yu, S. Bhattacharya, R. T. Branson, K. Akashi, and P. Sicinski. 2004. Mouse development and cell proliferation in the absence of D-cyclins. Cell 118:477-491.
42. Kushner, J. A., M. A. Ciemerych, E. Sicinska, L. M. Wartschow, M. Teta, S. Y. Long, P. Sicinski, and M. F. White. 2005. Cyclins D2 and D1 are essential for postnatal pancreatic β-cell growth. Mol. Cell. Biol. 25:3752-3762.
43. LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A., Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847-862.
44. Ladha, M. H., K. Y. Lee, T. M. Upton, M. F. Reed, and M. E. Ewen. 1998. Regulation of exit from quiescence by p27 and cyclin D1-CDK4. Mol. Cell. Biol. 18:6605-6615.
45. Lam, E. W., J. Glassford, L. Banerji, N. S. Thomas, P. Sicinski, and G. G. Klaus. 2000. Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. J. Biol. Chem. 275:3479-3484.
46. Liang, J., J. Zubovitz, T. Petrocelli, R. Kotchetkov, M. K. Connor, K. Han, J. H. Lee, S. Ciarallo, C. Catzavelos, R. Beniston, E. Franssen, and J. M. Slingerland. 2002. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8:1153-1160.
47. Lukas, J., J. Bartkova, M. Welcker, O. W. Petersen, G. Peters, M. Strauss, and J. Bartek. 1995. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene 10:2125-2134.
48. Malumbres, M., R. Sotillo, D. Santamaria, J. Galan, A. Cerezo, S. Ortega, P. Dubus, and M. Barbacid. 2004. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118:493-504.
49. Matsushime, H., M. E. Ewen, D. K. Strom, J. Y. Kato, S. K. Hanks, M. F. Roussel, and C. J. Sherr. 1992. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71:323-334.
50. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
51. Matsushime, H., M. F. Roussel, R. A. Ashmun, and C. J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701-713.
52. kip1. Nature 404:782-787.
53. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077-2086.
54. Meyyappan, M., H. Wong, C. Hull, and K. T. Riabowol. 1998. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol. Cell. Biol. 18:3163-3172.
55. Millard, S. S., A. Vidal, M. Markus, and A. Koff. 2000. A U-rich element in the 5′ untranslated region is necessary for the translation of p27 mRNA. Mol. Cell. Biol. 20:5947-5959.
56. Montagnoli, A., F. Fiore, E. Eytan, A. C. Carrano, G. F. Draetta, A. Hershko, and M. Pagano. 1999. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13:1181-1189.
57. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7:1063-1066.
58. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720.
59. Kip1, polyploidy and centrosome overduplication. EMBO J. 19:2069-2081.
60. Nakayama, K., H. Nagahama, Y. A. Minamishima, S. Miyake, N. Ishida, S. Hatakeyama, M. Kitagawa, S. Iemura, T. Natsume, and K. I. Nakayama. 2004. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev. Cell 6:661-672.
61. Nakayama, K. I., and K. Nakayama. 2006. Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6:369-381.
62. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573.
63. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
64. Kip1 expression. J. Biol. Chem. 276:23572-23580.
65. Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11:492-503.
66. Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831-1845.
67. Rodier, C., A. Montagnoli, L. Di Marcotullio, P. Coulombe, G. F. Draetta, M. Pagano, and S. Meloche. 2001. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J. 20:6672-6682.
68. Schmidt, B. A., A. Rose, C. Steinhoff, T. Strohmeyer, M. Hartmann, and R. Ackermann. 2001. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. Cancer Res. 61:4214-4221.
69. Kip1. Genes Dev. 11:1464-1478.
70. Sherr, C. J., and J. M. Roberts. 2004. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18:2699-2711.
71. Kip1 at threonine 157 and modulation of its cellular localization. Nat. Med. 8:1145-1152.
72. Sicinski, P., J. L. Donaher, Y. Geng, S. B. Parker, H. Gardner, M. Y. Park, R. L. Robker, J. S. Richards, L. K. McGinnis, J. D. Biggers, J. J. Eppig, R. T. Bronson, S. J. Elledge, and R. A. Weinberg. 1996. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470-474.
73. Solvason, N., W. W. Wu, D. Parry, D. Mahony, E. W. Lam, J. Glassford, G. G. Klaus, P. Sicinski, R. Weinberg, Y. J. Liu, M. Howard, and E. Lees. 2000. Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. Int. Immunol. 12:631-638.
74. Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol. 1:207-214.
75. Takano, Y., Y. Kato, P. J. van Diest, M. Masuda, H. Mitomi, and I. Okayasu. 2000. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am. J. Pathol. 156:585-594.
76. Kip1 is instigated by Jab1. Nature 398:160-165.
77. Skp2 complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661-664.
78. Uchida, T., T. Nakamura, N. Hashimoto, T. Matsuda, K. Kotani, H. Sakaue, Y. Kido, Y. Hayashi, K. I. Nakayama, M. F. White, and M. Kasuga. 2005. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat. Med. 11:175-182.
79. van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2054.
80. Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 8:1136-1144.
81. Vlach, J., S. Hennecke, and B. Amati. 1997. Phosphorylation- dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16:5334-5344.
82. Kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo. Blood 105:3691-3698.
83. Zwijsen, R. M., E. Wientjens, R. Klompmaker, J. van der Sman, R. Bernards, and R. J. Michalides. 1997. CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405-415.